Bodal Chemicals Limited (BODALCHEM) AI Stock Analysis

• Market Cap: ₹6.65B
• Dividend Yield: N/A
• Average Volume (3M): 9.69K
• Price to Earnings (P/E): 18.8
• Beta (1Y): 1.46
• Revenue Growth: 15.56%
• EPS Growth: 2114.71%
• Country: IN
• Employees: 2,133
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 0.48
• Shares Outstanding: 125,944,060
• 10 Day Avg. Volume: 13,655
• 30 Day Avg. Volume: 9,685
• PEG Ratio: 0.22
• Price to Book (P/B): 0.70
• Price to Sales (P/S): 0.45
• P/FCF Ratio: -93.18
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 410.35
• Revenue Forecast (FY): ₹1.79T

• Rating: 52 Neutral
• Price Target: ₹55.00 ▲(4.17% Upside)

Bodal Chemicals' overall score is primarily impacted by its financial performance, which shows strong revenue growth but low profitability and cash flow concerns. Technical analysis indicates bearish momentum, further weighing down the score. Valuation is moderate, but the lack of a dividend yield reduces its appeal.

Positive Factors

Revenue Growth

Strong revenue growth indicates expanding market presence and product demand, supporting long-term business sustainability and scaling potential.

Operational Efficiencies

Enhanced operational efficiencies suggest effective cost management and productivity improvements, which can lead to better profitability over time.

Stable Balance Sheet

A stable balance sheet with manageable debt levels provides financial flexibility and reduces risk, supporting long-term strategic initiatives.

Negative Factors

Low Net Profit Margin

A low net profit margin indicates challenges in converting revenue into profits, which could hinder reinvestment and growth opportunities.

Negative Free Cash Flow

Negative free cash flow suggests potential liquidity issues and limits the company's ability to fund operations and investments without external financing.

Low Return on Equity

Low ROE indicates inefficiencies in generating profits from shareholders' equity, which may impact investor confidence and long-term growth.

Bodal Chemicals Limited Business Overview & Revenue Model

Company Description

Bodal Chemicals Limited manufactures and sells dyestuffs, dyes intermediates, and other chemicals in India. The company's dye intermediates primarily include vinyl sulphone ester, ortho anisidine vinyl sulphone, meta ureido aniline, H. acid, Bronner's vinyl sulphone, vinyl sulphone paracresidine base, 6-nitro 1-diazo-2naphthol 4-sulphonic acid, sulpho para vinyl sulphone, sulpho tobias acid, vinyl sulphone ester of 2:5 di methoxy aniline, sulpho ortho anisidine vinyl sulphone, F.C. acid, 1:2:4 diazo, K–acid, benzedine di sulphonic acid, benzanilide vinyl sulphone, and gamma acid. It also provides reactive, acid, and direct dyes for textile, leather, and paper industries; and sulphuric acid, chloro sulphonic acid, liquid SO3, oleums, beta napthol, linear alkyl benzene sulphonic acid, and acetanilide that are used as raw materials for the production of dye intermediates. Bodal Chemicals Limited also exports its products. The company was formerly known as Dintex Dyechem Limited and changed its name to Bodal Chemicals Limited in May 2006. Bodal Chemicals Limited was incorporated in 1986 and is headquartered in Ahmedabad, India.

How the Company Makes Money

Bodal Chemicals generates revenue primarily through the sale of its specialty chemicals and dyestuffs. The company operates on a B2B model, supplying its products to manufacturers in various industries, which constitute its key revenue streams. Additionally, BodalChem benefits from long-term contracts and partnerships with major textile and chemical companies, ensuring a steady demand for its products. The company also may engage in export activities, leveraging its manufacturing capabilities to reach international markets, which further enhances its revenue potential. Factors such as economies of scale, operational efficiencies, and a focus on research and development to innovate new products contribute significantly to Bodal's earnings.

Bodal Chemicals Limited Financial Statement Overview

Summary

Bodal Chemicals shows strong revenue growth and improved operational efficiencies with rising gross and EBIT margins. However, low net profit margin and negative free cash flow raise concerns about long-term sustainability. The balance sheet is stable with a strong equity position and manageable debt levels.

Income Statement

Bodal Chemicals has shown a mixed performance in its income statement. The company experienced a solid revenue growth rate of 25.12% from the previous year to 2025. However, its net profit margin is relatively low at 1.06%, reflecting challenges in converting revenues into profits. The gross profit margin improved significantly to 38.71% in 2025, indicating better cost management. The EBIT margin of 5.65% also shows a positive trend from prior years, suggesting operational efficiency improvements. Despite these positives, the low net profit margin remains a concern.

Balance Sheet

The balance sheet reveals a stable financial structure for Bodal Chemicals. The debt-to-equity ratio stands at 0.82, indicating a balanced approach to leveraging. The company's equity ratio of 46.94% suggests a strong equity base, although there is room for improvement. Return on equity (ROE) is low at 1.67%, highlighting inefficiencies in generating profits from equity. Overall, Bodal Chemicals maintains a stable financial position with manageable debt levels.

Cash Flow

The cash flow statement shows Bodal Chemicals facing challenges in generating free cash flow, with a negative free cash flow in 2025. The operating cash flow to net income ratio is positive at 2.06, indicating that the company generates more cash than accounting profits, which is a positive sign. However, the negative free cash flow growth rate from 2024 to 2025 reflects ongoing capital expenditure pressures. The free cash flow to net income ratio is negative, pointing to potential liquidity issues if not addressed.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	17.77B	17.45B	13.95B	15.63B	20.27B	12.21B
Gross Profit	8.33B	6.76B	1.68B	6.70B	5.42B	3.29B
EBITDA	1.84B	1.69B	1.19B	1.45B	2.16B	1.00B
Net Income	292.10M	185.02M	64.69M	380.33M	1.04B	419.82M
Balance Sheet
Total Assets	0.00	23.53B	22.88B	21.21B	21.22B	17.48B
Cash, Cash Equivalents and Short-Term Investments	360.60M	360.60M	462.50M	225.87M	93.95M	119.14M
Total Debt	0.00	9.11B	8.47B	6.98B	5.76B	3.47B
Total Liabilities	-11.05B	12.48B	12.06B	10.43B	10.70B	7.68B
Stockholders Equity	11.05B	11.05B	10.82B	10.78B	10.56B	9.81B
Cash Flow
Free Cash Flow	0.00	-83.36M	-407.19M	-528.49M	-1.73B	-1.91B
Operating Cash Flow	0.00	381.14M	2.04B	2.85B	-135.20M	-130.17M
Investing Cash Flow	0.00	-424.34M	-2.62B	-3.10B	-1.70B	-1.68B
Financing Cash Flow	0.00	76.36M	809.81M	326.55M	1.81B	1.78B

Bodal Chemicals Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 52.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BODALCHEM, the sentiment is Negative. The current price of 52.8 is above the 20-day moving average (MA) of 52.74, below the 50-day MA of 56.82, and below the 200-day MA of 65.52, indicating a neutral trend. The MACD of -1.47 indicates Negative momentum. The RSI at 43.66 is Neutral, neither overbought nor oversold. The STOCH value of 55.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BODALCHEM.

Bodal Chemicals Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SHREEPUSHK	68 Neutral	₹12.21B	17.05	―	0.53%	28.67%	50.12%
AGARIND	63 Neutral	₹10.63B	12.77	―	0.47%	-4.09%	-32.35%
BHAGERIA	63 Neutral	₹7.95B	15.59	―	0.83%	33.39%	85.08%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
KIRIINDUS	60 Neutral	₹34.16B	26.01	―	―	-22.04%	-58.81%
BODALCHEM	52 Neutral	₹6.65B	18.76	―	―	15.56%	2114.71%
FAIRCHEMOR	47 Neutral	₹8.91B	147.03	―	1.09%	-22.10%	-85.56%

Bodal Chemicals Limited Corporate Events

Bodal Chemicals Releases Q3 2025 Financial Results

Bodal Chemicals Limited has announced the publication of its unaudited standalone and consolidated financial results for the quarter ending September 30, 2025. These results, approved by the Board of Directors on November 12, 2025, were published in The Indian Express and Financial Express on November 13, 2025. This announcement indicates the company’s commitment to transparency and provides stakeholders with insights into its financial performance for the specified period.